Dobutamine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Dobutamine and local guidelines before prescribing.

Inotrope (beta-1 agonist)

Mechanism

Beta-1 agonist increasing inotropy with mild vasodilation.

Uses

Cardiogenic shock and low-output states; stress echocardiography.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Tachycardia, arrhythmias, hypotension, hypokalaemia.

Interactions

Beta-blockers antagonise effect; MAOIs potentiate.

Contraindications and cautions

Hypertrophic obstructive cardiomyopathy, tachyarrhythmias

Monitoring

Continuous ECG, BP, urine output

Pregnancy and breastfeeding

Use if essential

Renal and hepatic impairment

No adjustment

Overdose and reversal

Stop; short half-life

Special advice

Central or large peripheral vein; titrate to response; monitor continuously.

More from the textbook: uses, cautions and other points
Where it is discussed in the book